摘要
Schlemm管成形术（canaloplasty）作为一种新的非穿透性手术越来越引起人们的重视，它通过扩张Schlemm管重建自然房水外流通道以加强房水外流，从而达到降低眼压的目的。Schlemm管成形术手术成功率在原发性开角型青光眼与小梁切除术类似。其优点包括：降眼压作用是非滤过泡依赖性的，术中不需要使用抗代谢药物，因而与滤过泡相关的并发症极低。但这项新技术大范围应用于临床仍有很长的路要走。
As a non-penetrating glaucoma surgery （NPGS）, canaloplasty has aroused a growing number of attention, which aims to restore the physiological outflow by dilating the Schlemm＇ s canal, thus facilitating aqueous outflow to treat glaucoma. The success rate of canaloplasty is equal to trabeculectomy in primary open angle glaucoma. The surgery shows lots of advantages ： the effect of intraocular pressure-reduc- ing is non-bleb related, no filtering blebs were detected, no antimetabolites were required during surgery, thus leading a low rate of bleb-related complications. However there is a long way to apply the new technical in clinic.
出处
《国际眼科纵览》
2015年第5期341-345,共5页
International Review of Ophthalmology
